Freeze-drying of Low molecular weight poly(L-lactic acid) nanoparticles: Effect of cryo- And lyoprotectants

Journal of Nanoscience and Nanotechnology

Volumn 6, Issue 9-10, 2006, Pages 3110-3117

  Hirsjärvi, Samuli ^a   Peltonen, Leena ^a   Kainu, Laura ^a   Hirvonen, Jouni ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Freeze Drying; Glucose; Lactose; Nanoparticles; Nanoprecipitation; Tween 80

Indexed keywords

LACTOSE; LYOPROTECTANTS; POLYLACTIC ACIDS; REDISPERSION;

DRYING; FREEZING; GLUCOSE; MOLECULAR WEIGHT; SOLUTIONS; SUSPENSIONS (COMPONENTS);

NANOSTRUCTURED MATERIALS;

CRYOPROTECTIVE AGENT; GLUCOSE; LACTIC ACID; LACTOSE; NANOMATERIAL; POLYLACTIC ACID; POLYMER;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CRYSTALLIZATION; DRUG STABILITY; EVALUATION; FREEZE DRYING; MATERIALS TESTING; METHODOLOGY; MOLECULAR WEIGHT; PARTICLE SIZE; ULTRASTRUCTURE;

CRYOPROTECTIVE AGENTS; CRYSTALLIZATION; DRUG STABILITY; FREEZE DRYING; GLUCOSE; LACTIC ACID; LACTOSE; MATERIALS TESTING; MOLECULAR WEIGHT; NANOSTRUCTURES; PARTICLE SIZE; POLYMERS;

EID: 33750060454     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2006.439     Document Type: Conference Paper

References (28)

1. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, Int. J. Pharm. 55, R1 (1989).
2. T. Govender, S. Stolnik, M. C. Garnett, L. Illum, and S. S. Davis, J. Control. Rel. 57, 171 (1999).
3. L. Peltonen, P. Koistinen, M. Karjalainen, A. Häkkinen, and J. Hirvonen, MPS Pharm. Sci. Tech. 3, article 32 (2002).
4. L. Peltonen, P. Koistinen, and J. Hirvonen, STP Pharma Sci. 13, 299 (2003).
5. L. Peltonen, J. Aitta, S. Hyvönen, M. Karjalainen, and J. Hirvonen, AAPS Pharm. Sci. Tech. 5, article 16 (2004).
6. A. Saez, M. Guzman, J. Molpeceres, and M. R. Aberturas, Eur. J. Pharm. Biopharm. 50, 379 (2000).
7. Y. N. Konan, R. Gurny, and E. Allemann, Int. J. Pharm. 233, 239 (2002).
8. B. Wichert and J. Rohdewald, J. Control. Rel. 14, 269 (1990).
9. B. Wichert and J. Rohdewald, J. Microencapsul. 10, 195 (1993).
10. F. Franks, Eur. J. Pharm. Biopharm. 45, 221 (1998).
11. S. de Chasteigner, H. Fessi, G. Cave, J. P. Devissaguet, and F. Puisieux, STP Pharma Sci. 5, 242 (1995).
12. F. de Jaeghere, E. Allémann, J.-C. Leroux, W. Stevels, J. Feijen, E. Doelker, and R. Gurny, Pharm. Res. 16, 859 (1999).
13. W. Abdelwahed, G. Degobert, and H. Fessi, Int. J. Pharm. 309, 178 (2006).
14. D. Quintanar-Guerrero, A. Ganem-Quintanar, E. Allémann, H. Fessi, and E. Doelker, J. Microencapsul. 15, 107 (1998).
15. K. Tanaka, T. Takeda, K. Fujii, and K. Miyajima, Chem. Pharm. Bull. 40, 1 (1992).
16. T. W. Randolph, J. Pharm. Sci. 86, 1198 (1997).
17. K. Miyajima, Adv. Drug Deliv. Rev. 24, 151 (1997).
18. C.-M. Chiang, G. L. Flynn, N. D. Weiner, and G. J. Szpunar, Int. J. Pharm. 55, 229 (1989).
19. J.-C. Tsai, M. J. Cappel, G. L. Flynn, N. D. Weiner, J. Kreuter, and J. J. Ferry, J. Pharm. Sci. 81, 736 (1992).
20. J. F. Carpenter, M. J. Pikal, B. S. Chang, and T. W. Randolph, Pharm. Res. 14, 969 (1997).
21. D. N. Travers, Pharmaceutics: The Science of Dosage form Design, edited by M. E. Aulton, Churchill Livingstone, London (1988), p. 629.
22. E. R. Caffarena and J. R. Grigera, Carbohydrate Res. 300, 51 (1997).
23. P. P. Lewicki, J. Food Eng. 61, 483 (2004).
24. M. F. Mazzobre, J. M. Aguilera, and M. P. Buera, Carbohydrate Res. 338, 541 (2003).
25. G. L. Zubay, Biochemistry, McGraw-Hill Companies Inc., New York (1998), p. 283, 4th edn.
26. S. de Chasteigner, G. Cave, H. Fessi, J.-P. Devissaguet, and F. Puisieux, Drug Dev. Res. 38, 116 (1996).
27. L. A. Dailey, T. Schmehl, T. Gessler, M. Wittmar, F. Grimminger, W. Seeger, and T. Kissel, J. Control. Rel. 86, 131 (2003).
28. M. Malmsten, Surfactants and Polymers in Drug Delivery, Marcel Dekker Inc., New York (2002), p. 51, 1st edn.